Literature DB >> 16353398

A mutation in Wolfram syndrome type 1 gene in a Japanese family with autosomal dominant low-frequency sensorineural hearing loss.

Yoshihiro Noguchi1, Takatoshi Yashima, Akio Hatanaka, Masamichi Uzawa, Michio Yasunami, Akinori Kimura, Ken Kitamura.   

Abstract

CONCLUSION: Our findings suggest that Wolfram syndrome type 1 gene (WFS1) mutation is an important cause of autosomal dominant low-frequency sensorineural hearing loss (LFSNHL) in Japan.
OBJECTIVE: DFNA6/14 is caused by a heterozygous mutation of WFS1 and is a common cause of autosomal dominant LFSNHL among populations in both Europe and the US. The purpose of this study was to investigate WFS1 mutations among Japanese patients whose phenotypes were consistent with those of DFNA6/14.
MATERIAL AND METHODS: Using audiometry and genetic analysis, we searched for WFS1 mutations in three unrelated Japanese patients with LFSNHL and a familial history of autosomal dominant hearing loss.
RESULTS: One patient carried a heterozygous G2700A mutation at codon 844 in exon 8, resulting in substitution of a threonine for an alanine (A844T). Genetic analysis of the available members of the patient's family showed that the A844T mutation segregated with LFSNHL, but was not detected in any of 140 control chromosomes. It thus appears likely that the A844T mutation is causative for hearing loss in this group. Speech audiometry, self-recording audiometry and auditory brainstem responses showed the patient to have cochlear deafness without retrocochlear dysfunction. No mutation was found in the other two patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16353398     DOI: 10.1080/00016480510044232

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  7 in total

1.  Clinical and molecular assessment of 13 Iranian families with Wolfram syndrome.

Authors:  Maryam Sobhani; Mohammad Amin Tabatabaiefar; Soudeh Ghafouri-Fard; Asadollah Rajab; Sarah Mozafarpour; Samaneh Nasrniya; Abdol-Mohammad Kajbafzadeh; Mohammad Reza Noori-Daloii
Journal:  Endocrine       Date:  2019-07-16       Impact factor: 3.633

2.  Mutations in the WFS1 gene are a frequent cause of autosomal dominant nonsyndromic low-frequency hearing loss in Japanese.

Authors:  Hisakuni Fukuoka; Yukihiko Kanda; Shuji Ohta; Shin-Ichi Usami
Journal:  J Hum Genet       Date:  2007-05-11       Impact factor: 3.172

Review 3.  Wolfram syndrome: MAMs' connection?

Authors:  Benjamin Delprat; Tangui Maurice; Cécile Delettre
Journal:  Cell Death Dis       Date:  2018-03-06       Impact factor: 8.469

4.  WFS1 mutation screening in a large series of Japanese hearing loss patients: Massively parallel DNA sequencing-based analysis.

Authors:  Masafumi Kobayashi; Maiko Miyagawa; Shin-Ya Nishio; Hideaki Moteki; Taro Fujikawa; Kenji Ohyama; Hirofumi Sakaguchi; Ikuyo Miyanohara; Akiko Sugaya; Yasushi Naito; Shin-Ya Morita; Yukihiko Kanda; Masahiro Takahashi; Kotaro Ishikawa; Yuki Nagano; Tetsuya Tono; Chie Oshikawa; Chiharu Kihara; Haruo Takahashi; Yoshihiro Noguchi; Shin-Ichi Usami
Journal:  PLoS One       Date:  2018-03-12       Impact factor: 3.240

5.  A Novel Missense WFS1 Variant: Expanding the Mutational Spectrum Associated with Nonsyndromic Low-Frequency Sensorineural Hearing Loss.

Authors:  Jingyu Ma; Rongrong Wang; Li Zhang; Shanshan Wang; Shuqing Tong; Xiaohui Bai; Zhiming Lu
Journal:  Biomed Res Int       Date:  2022-10-03       Impact factor: 3.246

6.  A novel mutation in the WFS1 gene identified in a Taiwanese family with low-frequency hearing impairment.

Authors:  Hsun-Tien Tsai; Ying-Piao Wang; Shing-Fang Chung; Hung-Ching Lin; Guan-Min Ho; Min-Tsan Shu
Journal:  BMC Med Genet       Date:  2007-05-22       Impact factor: 2.103

7.  A novel WFS1 mutation in a family with dominant low frequency sensorineural hearing loss with normal VEMP and EcochG findings.

Authors:  Naomi F Bramhall; Jeremy C Kallman; Aimee M Verrall; Valerie A Street
Journal:  BMC Med Genet       Date:  2008-06-02       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.